Editor’s Letter
Lagging acceptance of generic and biosimilar drug products; the rest of the story
Page: 3-4
The articles in this issue of the GaBI Journal reminded me of The Rest of the Story radio programme originally hosted by Mr Paul Harvey that started each episode with,… Read More »
The importance of trust
It seems as if the entire world is dealing with a lack of trust, even in many things that have enriched and sustained human development, including our neighbours, teachers, the… Read More »
What to look forward to in GaBI Journal, 2022, Issue 2
The rate of successful development, regulatory approval and marketing of both new and follow-on biological treatments has continued to accelerate despite, and in some cases because of, a seemingly endless… Read More »
First 2022 GaBI Journal issue highlights
The first GaBI Journal issue of 2022 comes at a time of both hope and despair. While the COVID-19 pandemic continues to cause significant global morbidity and mortality; especially in… Read More »
Fourth and final issue of GaBI Journal’s 10th volume
This issue of the GaBI Journal contains only a limited number of articles, but these include two scientific very data-rich articles and an interesting and important expose on the use… Read More »
Latest features in GaBI Journal, 2021, Issue 3
This issue of GaBI Journal contains articles dealing with some very practical issues related to the evaluation, describing, and use of generic and biosimilar products. These issues include the uncertainty… Read More »
What to look forward to in GaBI Journal, 2021, Issue 2
The current pandemic has greatly amplified the already existing disparities in access to health care. Many countries are facing a lack of access to or funding to pay for the… Read More »
First 2021 GaBI Journal issue highlights
The articles in this first issue contain a large volume of useful information on the global development, approval, manufacturing, marketing, and uptake of biosimilars. The first Original Research by Dr… Read More »
Medical journal publication during global stress
This issue of the GaBI Journal is being published during one of the most turbulent periods in over a century. A deadly pandemic is raging, the global economy is stressed,… Read More »
Latest features in GaBI Journal, 2020, Issue 3
The Commentary in this issue of the GaBI Journal by Dr Elwyn Griffiths discusses the need for more global harmonization of regulatory approaches to biological medicines. Dr Griffiths refers to… Read More »